Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT

Autor: Massimo F. Martelli, Piyanuch Kongtim, Paul O'Donnell, Monzr M. Al Malki, Philippe Lewalle, Rupert Handgretinger, Jorge Gayoso, Michael Maschan, Christoph Schmid, Norbert Claude Gorin, Andrea Bacigalupo, Denis-Claude Roy, Karen K. Ballen, Hillard M. Lazarus, Arnon Nagler, Myriam Labopin, Stephan Mielke, Alexandros Spyridonidis, Fabio Ciceri, A. Ruggeri, Asad Bashey, Yolande Arnault, Stefan O. Ciurea, Leo Luznik, Sebastian Giebel, Frédéric Baron, Mohamad Mohty, Ephraim J. Fuchs, Bipin N. Savani, Scott D. Solomon, Bhagirathbhai Dholaria, Franco Aversa, Xiao-Jun Huang, Didier Blaise, Franco Locatelli, Luca Castagna, Jordi Esteve, Patrick Ben Soussan, Rizwan Romee
Přispěvatelé: Dholaria, B., Savani, B. N., Labopin, M., Luznik, L., Ruggeri, A., Mielke, S., Al Malki, M. M., Kongtim, P., Fuchs, E., Huang, X. -J., Locatelli, F., Aversa, F., Castagna, L., Bacigalupo, A., Martelli, M., Blaise, D., Soussan, P. B., Arnault, Y., Handgretinger, R., Roy, D. -C., O'Donnell, P., Bashey, A., Solomon, S., Romee, R., Lewalle, P., Gayoso, J., Maschan, M., Lazarus, H. M., Ballen, K., Giebel, S., Baron, F., Ciceri, F., Esteve, J., Gorin, N. -C., Spyridonidis, A., Schmid, C., Ciurea, S. O., Nagler, A., Mohty, M.
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Haematologica
Haematologica, vol 105, iss 1
Haematologica, 105 (1
Popis: Donor lymphocyte infusion has been used in the management of relapsed hematologic malignancies after allogeneic hematopoietic cell transplantation. It can eradicate minimal residual disease or be used to rescue a hematologic relapse, being able to induce durable remissions in a subset of patients. With the increased use of haploidentical hematopoietic cell transplantation, there is renewed interest in the use of donor lymphocytes to either treat or prevent disease relapse post transplant. Published retrospective and small prospective studies have shown encouraging results with therapeutic donor lymphocyte infusion in different haploidentical transplantation platforms. In this consensus paper, finalized on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, we summarize the available evidence on the use of donor lymphocyte infusion from haploidentical donor, and provide recommendations on its therapeutic, pre-emptive and prophylactic use in clinical practice.
SCOPUS: re.j
info:eu-repo/semantics/published
Databáze: OpenAIRE